A Homozygous Mutation in Identified by Whole-exome Sequencing Ending a Diagnostic Odyssey
Overview
Authors
Affiliations
We present a patient with a unique neurological phenotype with a progressive neurodegenerative phenotype. An 18-year diagnostic odyssey for the patient ended when exome sequencing identified a homozygous mutation suggesting an atypical peroxisomal biogenesis disorder (PBD). Interestingly, the patient's peroxisomal biochemical abnormalities were subtle, such that plasma very-long-chain fatty acids initially failed to provide a diagnosis. This case suggests next-generation sequencing may be diagnostic in some atypical peroxisomal biogenesis disorders.
Gomez V, Kanca O, Jangam S, Srivastav S, Andrews J, Wangler M bioRxiv. 2024; .
PMID: 39605732 PMC: 11601393. DOI: 10.1101/2024.11.14.623590.
Thistlethwaite L, Li X, Burrage L, Riehle K, Hacia J, Braverman N Sci Rep. 2022; 12(1):6556.
PMID: 35449147 PMC: 9023513. DOI: 10.1038/s41598-022-10415-5.
Cheung A, Argyriou C, Yergeau C, DSouza Y, Riou E, Levesque S Neurogenetics. 2022; 23(2):115-127.
PMID: 35106698 DOI: 10.1007/s10048-022-00684-7.
LC-MS Based Platform Simplifies Access to Metabolomics for Peroxisomal Disorders.
Klemp H, Kettwig M, Streit F, Gartner J, Rosewich H, Kratzner R Metabolites. 2021; 11(6).
PMID: 34072483 PMC: 8226985. DOI: 10.3390/metabo11060347.
Expanding the concept of peroxisomal diseases and efficient diagnostic system in Japan.
Takashima S, Saitsu H, Shimozawa N J Hum Genet. 2018; 64(2):145-152.
PMID: 30237433 DOI: 10.1038/s10038-018-0512-1.